Product image of Meteospasmyl (Alverine Citrate, Simeticone) supplied by GNH India

Meteospasmyl

Active Ingredient:
Alverine Citrate, Simeticone
Origin:
EU

Meteospasmyl (Alverine Citrate, Simeticone)

Alverine citrate, the active ingredient in Meteospasmyl, is an antispasmodic presented as an oral formulation for oral use. Combined with simethicone, it targets functional gastrointestinal disorders by relaxing smooth‑muscle spasms and reducing intestinal gas, thereby alleviating abdominal pain, bloating and flatulence in adult patients.

GNH India supplies Meteospasmyl as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to WHO‑GMP guidelines and provides batch‑tested products for reliable global distribution, ensuring consistent potency and safety across markets.

Manufacturer / TM Owner

Laboratoires Mayoly Spindler

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Meteospasmyl is used to manage functional gastrointestinal disorders that involve smooth‑muscle spasm and excess intestinal gas.

  • Abdominal pain: reduces discomfort by relaxing intestinal smooth muscle.
  • Bloating: diminishes the sensation of abdominal fullness through antifoaming action.
  • Flatulence: facilitates the elimination of gas bubbles in the gut.
  • Irritable bowel syndrome: helps control recurrent abdominal cramps and gas‑related symptoms.

How It Works

  • Alverine citrate acts as a direct smooth‑muscle relaxant in the gastrointestinal tract, decreasing spasm by inhibiting calcium influx in smooth‑muscle cells. Simethicone, an antifoaming agent, lowers the surface tension of gas bubbles, allowing them to coalesce and be expelled more easily, thereby relieving bloating and flatulence.

Side Effects

Meteospasmyl is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects

  • Nausea: mild to moderate upset stomach.
  • Headache: transient cranial discomfort.
  • Dizziness: occasional light‑headed sensation.
  • Dry mouth: reduced salivation.
  • Abdominal discomfort: mild cramping.

Serious or Rare Side Effects

  • Allergic reactions: rash, itching, or angioedema.
  • Severe abdominal pain: persistent or worsening pain.
  • Difficulty breathing: signs of bronchospasm or anaphylaxis.
  • Swelling of face, lips, or tongue.
  • Unexplained fainting or loss of consciousness.

Precautions & Warnings

Before using Meteospasmyl, consider the following safety measures.

  • Pregnancy: consult a healthcare professional; safety data are limited.
  • Breastfeeding: use with caution; potential transfer to milk is unknown.
  • Renal impairment: monitor for accumulation and adjust if necessary.
  • Elderly patients: start with the lowest effective dose and watch for side effects.
  • Concomitant medications: review all current drugs for possible interactions.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Avoid Interactions

Meteospasmyl may interact with other medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid)

  • Combined use with other antispasmodics: may increase anticholinergic burden.
  • Simethicone taken with certain oral antibiotics (e.g., tetracyclines): can reduce antibiotic absorption.

Moderate Interactions (Monitor Closely)

  • Concurrent anticholinergic agents: monitor for excessive dry mouth or constipation.
  • Drugs affecting gastrointestinal motility (e.g., prokinetics): observe for additive effects.
  • Herbal supplements containing peppermint oil: may enhance spasmolytic action.
  • Over‑the‑counter analgesics (NSAIDs): watch for increased gastrointestinal irritation.

Frequently Asked Questions

Meteospasmyl is indicated for the relief of abdominal pain, bloating, flatulence and the abdominal discomfort associated with irritable bowel syndrome. It works by relaxing intestinal smooth muscle and reducing gas bubbles, helping to alleviate the typical symptoms of functional gastrointestinal disorders.

Alverine citrate acts as a direct smooth‑muscle relaxant in the gastrointestinal tract. It inhibits calcium influx into smooth‑muscle cells, which reduces spasm and eases cramping. When combined with simethicone, the formulation also helps eliminate trapped gas, providing dual symptom control.

The appropriate dose of Meteospasmyl is determined by a qualified prescriber based on the individual’s condition, age, and response to therapy. Patients should follow the healthcare professional’s instructions and not adjust the dose without medical advice.

Safety data for Meteospasmyl in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the Meteospasmyl product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Meteospasmyl combines an antispasmodic (alverine citrate) with an antifoaming agent (simethicone), offering both muscle relaxation and gas‑elimination. Many other antispasmodics lack the simethicone component, so Meteospasmyl may provide broader symptom relief for patients experiencing both cramps and excess gas.

Meteospasmyl should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Meteospasmyl is taken orally, usually with a glass of water. The exact timing relative to meals or other medications should follow the prescribing clinician’s guidance to optimise absorption and effectiveness.

Serious risks, though rare, include allergic reactions such as rash, angioedema, or anaphylaxis, and severe abdominal pain that does not improve. Patients should seek immediate medical attention if they experience any signs of a severe hypersensitivity reaction or worsening gastrointestinal symptoms.

Meteospasmyl is contraindicated in individuals with known hypersensitivity to alverine citrate, simethicone, or any excipients in the formulation. Patients with severe hepatic or renal impairment should consult a physician before use, as dose adjustments may be required.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Alverine Citrate, Simeticone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT